FDA Weighs Clinician-Style Tests for Generative AI Medical Devices - PYMNTS.com
Reported by PYMNTS.com · all stories from pymnts.com
Editorial digest
The Food and Drug Administration is evaluating the use of clinician-like testing methods for generative artificial intelligence medical devices, to ensure their practical effectiveness.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at PYMNTS.com →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom8/20/2026
FDA weighs regulatory approach for genAI medical devices - MobiHealthNews
The FDA is deliberating its regulatory strategy for generative AI medical devices.
- Trusted health newsroom9/3/2026
STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorized
FDA pilot program allows generative AI devices to reach patients pre-authorization.
- Trusted health newsroom8/18/2026
FDA seeks feedback on potential regulatory approaches for generative AI-enabled medical devices | AHA News - American Hospital Association
The FDA seeks input on regulating generative AI for medical devices.
- Trusted health newsroom11/3/2026
STAT+: FDA, CMS look to collaborate with states on health AI
Federal regulators at the FDA and CMS plan to partner with state authorities regarding medical artificial intelligence.
- Trusted health newsroom8/4/2026
STAT+: Are AI scribes medical devices? U.K. regulator weighs in
The U.K. regulator is evaluating AI scribes as medical devices.
- Trusted health newsroom10/30/2026
STAT+: FDA, CMS scramble to avoid regulatory logjam as more states look to test AI in clinical settings
Federal health agencies are working quickly to prevent oversight bottlenecks as states prepare clinical artificial intelligence trials.